Breathing in #ELCC23!
To mark ELCC, Martin Vogel, our EMEA Therapeutic Lead for Oncology, discusses how targeted treatments are the next frontier for lung cancer patients.
Our Therapy Areas
We focus on six areas of medicine where the need is high, the science is compelling, and where we can make the biggest difference:
Transparency
Janssen EMEA is committed to increasing transparency when it comes to the relationships between pharmaceutical companies and HCPs/HCOs. Through the disclosure of transfers of value, we aim to build a better understanding of these collaborations and more recognition of their value to patient care.